Related Experiment Video
Updated: Apr 21, 2026
05:45
Author Spotlight: Enhanced Generation of Patient-Derived 3D Organoids for Glioblastoma and Glioma
Published on: January 19, 2024
3.2K
[Low-grade gliomas in adults]
Tobias Kratzsch1, Oliver P Gautschi2, Susanne A Kuhn3
1Klinik für Neurochirurgie, Kantonsspital St. Gallen und Klinik für Neurochirurgie, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
Praxis
|November 14, 2014
Summary
Low-grade gliomas (LGG) are slow-growing brain tumors primarily affecting young adults, often presenting with seizures. Surgical resection is the primary treatment, with adjuvant therapies guided by biomarkers for personalized patient management.
Area of Science:
- Neuro-oncology
- Molecular Pathology
Context:
- Low-grade gliomas (LGG) represent a heterogeneous group of primary brain tumors.
- These tumors predominantly affect young adults and are histopathologically classified as WHO grade I or II.
- Common LGG subtypes include diffuse astrocytomas, oligodendrogliomas, and mixed gliomas.
Purpose:
- To outline current therapeutic strategies for low-grade gliomas.
- To highlight the importance of molecular biomarkers in guiding treatment decisions.
- To emphasize the need for an individualized approach to LGG management.
Summary:
- Surgical resection aiming for complete tumor removal is the recommended first-line therapy for accessible LGGs, significantly improving overall survival.
- The decision for adjuvant chemotherapy or radiotherapy requires careful interdisciplinary discussion.
- Key biomarkers such as O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, 1p/19q codeletion (LOH 1p/19q), and isocitrate dehydrogenase (IDH1/2) mutations are crucial for predicting treatment response and patient outcomes.
Impact:
- Biomarker-driven stratification holds promise for tailoring treatment plans for LGG patients.
- Personalized therapeutic strategies can optimize outcomes and improve survival rates.
- Advancements in understanding LGG molecular pathology are paving the way for more effective and targeted therapies.
